Cargando…
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge
Mycobacterium tuberculosis (Mtb) infects one-third of the world’s population and is a leading cause of death from a single infectious agent. New TB vaccines are urgently needed to augment immunity conferred by the current modestly protective BCG vaccine. We have developed live attenuated recombinant...
Autores principales: | Jia, Qingmei, Masleša-Galić, Saša, Nava, Susana, Horwitz, Marcus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764316/ https://www.ncbi.nlm.nih.gov/pubmed/36539517 http://dx.doi.org/10.1038/s42003-022-04345-1 |
Ejemplares similares
-
Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice
por: Jia, Qingmei, et al.
Publicado: (2022) -
Sex differences in the C57BL/6 model of Mycobacterium tuberculosis infection
por: Dibbern, Jannike, et al.
Publicado: (2017) -
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time
por: Lee, Bai-Yu, et al.
Publicado: (2017) -
Author Correction: Sex differences in the C57BL/6 model of Mycobacterium tuberculosis infection
por: Dibbern, Jannike, et al.
Publicado: (2018) -
Lung stiffness of C57BL/6 versus BALB/c mice
por: Rojas-Ruiz, Andrés, et al.
Publicado: (2023)